ATLAS GENOMICS Revenue and Competitors
Estimated Revenue & Valuation
- ATLAS GENOMICS's estimated annual revenue is currently $3.5M per year.
- ATLAS GENOMICS's estimated revenue per employee is $100,000
Employee Data
- ATLAS GENOMICS has 35 Employees.
- ATLAS GENOMICS grew their employee count by -12% last year.
ATLAS GENOMICS's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Molecular Site Director | Reveal Email/Phone |
2 | Program Manager - WA State Schools | Reveal Email/Phone |
3 | President | Reveal Email/Phone |
4 | Clinical Data Report Specialist | Reveal Email/Phone |
5 | Molecular Project Coordinator | Reveal Email/Phone |
ATLAS GENOMICS Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $258.5M | 898 | -10% | $1.1B | $2.4B |
What Is ATLAS GENOMICS?
ATLAS GENOMICS LLC is a company based out of 2296 W COMMODORE WAY # 220, SEATTLE, Washington, United States.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$3.5M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ATLAS GENOMICS News
2022-04-20 - Development and validation of an immune-related gene ...
Cancer Genome Atlas Research, N. et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481...
2022-04-17 - Substitution mutational signatures in whole-genome ...
Cancer genome sequencing studies permit exploration of mutational signatures ... Substantial efforts by The Cancer Genome Atlas (TCGA) (10),...
2022-03-30 - Complete genomic and epigenetic maps of human centromeres
By deeply characterizing these recently assembled sequences, we present a high-resolution, genome-wide atlas of the sequence content and organization of...
Other Companies in SEATTLE
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.8M | 35 | -53% | N/A |
#2 | $8.8M | 35 | 6% | N/A |
#3 | $3.7M | 35 | 6% | $17.2M |
#4 | $7.6M | 35 | 13% | N/A |
#5 | $4.1M | 35 | N/A | N/A |